nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Muscle strain—Metformin—polycystic ovary syndrome	0.0933	0.187	CcSEcCtD
Vigabatrin—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.0448	0.09	CcSEcCtD
Vigabatrin—Sinus headache—Metformin—polycystic ovary syndrome	0.0359	0.0721	CcSEcCtD
Vigabatrin—GABBR1—adrenal cortex—polycystic ovary syndrome	0.0332	0.0761	CbGeAlD
Vigabatrin—GABBR1—endometrium—polycystic ovary syndrome	0.0297	0.0679	CbGeAlD
Vigabatrin—GABBR1—uterus—polycystic ovary syndrome	0.0273	0.0626	CbGeAlD
Vigabatrin—GABBR1—pituitary gland—polycystic ovary syndrome	0.0268	0.0615	CbGeAlD
Vigabatrin—GABBR1—adipose tissue—polycystic ovary syndrome	0.0267	0.0612	CbGeAlD
Vigabatrin—GABBR1—adrenal gland—polycystic ovary syndrome	0.024	0.0549	CbGeAlD
Vigabatrin—GABBR1—female gonad—polycystic ovary syndrome	0.0224	0.0512	CbGeAlD
Vigabatrin—GABBR1—vagina—polycystic ovary syndrome	0.0222	0.0509	CbGeAlD
Vigabatrin—SLC36A1—uterus—polycystic ovary syndrome	0.0215	0.0492	CbGeAlD
Vigabatrin—SLC36A1—adipose tissue—polycystic ovary syndrome	0.021	0.0481	CbGeAlD
Vigabatrin—ABAT—pituitary gland—polycystic ovary syndrome	0.021	0.048	CbGeAlD
Vigabatrin—ABAT—adipose tissue—polycystic ovary syndrome	0.0209	0.0478	CbGeAlD
Vigabatrin—Toothache—Metformin—polycystic ovary syndrome	0.0192	0.0386	CcSEcCtD
Vigabatrin—SLC36A1—adrenal gland—polycystic ovary syndrome	0.0188	0.0431	CbGeAlD
Vigabatrin—ABAT—adrenal gland—polycystic ovary syndrome	0.0187	0.0429	CbGeAlD
Vigabatrin—Upset stomach—Metformin—polycystic ovary syndrome	0.0179	0.0359	CcSEcCtD
Vigabatrin—SLC36A1—female gonad—polycystic ovary syndrome	0.0176	0.0402	CbGeAlD
Vigabatrin—SLC36A1—vagina—polycystic ovary syndrome	0.0175	0.04	CbGeAlD
Vigabatrin—ABAT—female gonad—polycystic ovary syndrome	0.0175	0.04	CbGeAlD
Vigabatrin—ABAT—vagina—polycystic ovary syndrome	0.0174	0.0397	CbGeAlD
Vigabatrin—SLC36A1—endocrine gland—polycystic ovary syndrome	0.0163	0.0374	CbGeAlD
Vigabatrin—ABAT—endocrine gland—polycystic ovary syndrome	0.0162	0.0372	CbGeAlD
Vigabatrin—Contusion—Metformin—polycystic ovary syndrome	0.0134	0.0269	CcSEcCtD
Vigabatrin—Ear pain—Metformin—polycystic ovary syndrome	0.00995	0.02	CcSEcCtD
Vigabatrin—Nasal congestion—Metformin—polycystic ovary syndrome	0.00932	0.0187	CcSEcCtD
Vigabatrin—Lethargy—Metformin—polycystic ovary syndrome	0.00867	0.0174	CcSEcCtD
Vigabatrin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00849	0.0171	CcSEcCtD
Vigabatrin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00776	0.0156	CcSEcCtD
Vigabatrin—Breast disorder—Metformin—polycystic ovary syndrome	0.00767	0.0154	CcSEcCtD
Vigabatrin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00759	0.0153	CcSEcCtD
Vigabatrin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00739	0.0148	CcSEcCtD
Vigabatrin—Influenza—Metformin—polycystic ovary syndrome	0.00734	0.0147	CcSEcCtD
Vigabatrin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00704	0.0141	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00682	0.0137	CcSEcCtD
Vigabatrin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00654	0.0131	CcSEcCtD
Vigabatrin—Infestation—Metformin—polycystic ovary syndrome	0.00654	0.0131	CcSEcCtD
Vigabatrin—Drowsiness—Metformin—polycystic ovary syndrome	0.00654	0.0131	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00642	0.0129	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00619	0.0124	CcSEcCtD
Vigabatrin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00585	0.0117	CcSEcCtD
Vigabatrin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00579	0.0116	CcSEcCtD
Vigabatrin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00577	0.0116	CcSEcCtD
Vigabatrin—Eye disorder—Metformin—polycystic ovary syndrome	0.00549	0.011	CcSEcCtD
Vigabatrin—Malnutrition—Metformin—polycystic ovary syndrome	0.00511	0.0103	CcSEcCtD
Vigabatrin—Muscle spasms—Metformin—polycystic ovary syndrome	0.00492	0.00988	CcSEcCtD
Vigabatrin—Vision blurred—Metformin—polycystic ovary syndrome	0.00482	0.00968	CcSEcCtD
Vigabatrin—Tremor—Metformin—polycystic ovary syndrome	0.00479	0.00962	CcSEcCtD
Vigabatrin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00475	0.00953	CcSEcCtD
Vigabatrin—Malaise—Metformin—polycystic ovary syndrome	0.00461	0.00926	CcSEcCtD
Vigabatrin—Chest pain—Metformin—polycystic ovary syndrome	0.00435	0.00875	CcSEcCtD
Vigabatrin—Myalgia—Metformin—polycystic ovary syndrome	0.00435	0.00875	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00432	0.00869	CcSEcCtD
Vigabatrin—Discomfort—Metformin—polycystic ovary syndrome	0.0043	0.00864	CcSEcCtD
Vigabatrin—Oedema—Metformin—polycystic ovary syndrome	0.00417	0.00838	CcSEcCtD
Vigabatrin—Infection—Metformin—polycystic ovary syndrome	0.00415	0.00833	CcSEcCtD
Vigabatrin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00409	0.00822	CcSEcCtD
Vigabatrin—Skin disorder—Metformin—polycystic ovary syndrome	0.00405	0.00814	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0038	0.00764	CcSEcCtD
Vigabatrin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00375	0.00753	CcSEcCtD
Vigabatrin—Somnolence—Metformin—polycystic ovary syndrome	0.00371	0.00745	CcSEcCtD
Vigabatrin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00367	0.00738	CcSEcCtD
Vigabatrin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00363	0.00729	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0036	0.00724	CcSEcCtD
Vigabatrin—Fatigue—Metformin—polycystic ovary syndrome	0.0036	0.00723	CcSEcCtD
Vigabatrin—Constipation—Metformin—polycystic ovary syndrome	0.00357	0.00717	CcSEcCtD
Vigabatrin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00344	0.00691	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00341	0.00686	CcSEcCtD
Vigabatrin—Urticaria—Metformin—polycystic ovary syndrome	0.00332	0.00666	CcSEcCtD
Vigabatrin—Abdominal pain—Metformin—polycystic ovary syndrome	0.0033	0.00663	CcSEcCtD
Vigabatrin—Asthenia—Metformin—polycystic ovary syndrome	0.00299	0.00601	CcSEcCtD
Vigabatrin—Pruritus—Metformin—polycystic ovary syndrome	0.00295	0.00593	CcSEcCtD
Vigabatrin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00286	0.00574	CcSEcCtD
Vigabatrin—Dizziness—Metformin—polycystic ovary syndrome	0.00276	0.00554	CcSEcCtD
Vigabatrin—Vomiting—Metformin—polycystic ovary syndrome	0.00265	0.00533	CcSEcCtD
Vigabatrin—Rash—Metformin—polycystic ovary syndrome	0.00263	0.00529	CcSEcCtD
Vigabatrin—Dermatitis—Metformin—polycystic ovary syndrome	0.00263	0.00528	CcSEcCtD
Vigabatrin—Headache—Metformin—polycystic ovary syndrome	0.00262	0.00525	CcSEcCtD
Vigabatrin—Nausea—Metformin—polycystic ovary syndrome	0.00248	0.00498	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—NPB—polycystic ovary syndrome	0.00235	0.036	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.00196	0.03	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00169	0.0259	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00142	0.0218	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00138	0.0211	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00122	0.0186	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00122	0.0186	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.0012	0.0184	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00119	0.0182	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00119	0.0182	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00112	0.0171	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00111	0.017	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00109	0.0167	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00108	0.0165	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00108	0.0165	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00105	0.016	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00104	0.0158	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000933	0.0143	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000916	0.014	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000869	0.0133	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—DLG4—polycystic ovary syndrome	0.000825	0.0126	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000804	0.0123	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000795	0.0122	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000794	0.0121	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000765	0.0117	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000761	0.0116	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000756	0.0116	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000739	0.0113	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00073	0.0112	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000727	0.0111	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000712	0.0109	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000712	0.0109	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000709	0.0108	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—DLG4—polycystic ovary syndrome	0.000702	0.0107	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000676	0.0103	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000671	0.0103	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000671	0.0103	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000661	0.0101	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.000633	0.00968	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000628	0.0096	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00061	0.00932	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00061	0.00932	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00061	0.00932	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000593	0.00907	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00057	0.00872	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000554	0.00847	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000539	0.00825	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000538	0.00824	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000499	0.00764	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000494	0.00755	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000491	0.00752	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00049	0.00749	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000455	0.00695	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000449	0.00687	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000446	0.00682	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000433	0.00662	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000431	0.0066	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000427	0.00654	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000426	0.00652	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000423	0.00646	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000418	0.00639	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000413	0.00632	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000408	0.00624	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000401	0.00613	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000393	0.00601	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00039	0.00597	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000388	0.00594	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000387	0.00591	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000383	0.00586	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000382	0.00584	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000379	0.0058	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000364	0.00556	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00036	0.00551	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00036	0.00551	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000347	0.00531	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000337	0.00515	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000327	0.005	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000324	0.00496	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000318	0.00487	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00031	0.00474	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000289	0.00443	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000282	0.00432	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000264	0.00403	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000258	0.00395	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000256	0.00392	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000248	0.00379	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000241	0.00369	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FST—polycystic ovary syndrome	0.000235	0.00359	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000234	0.00357	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000232	0.00355	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000229	0.00351	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000224	0.00343	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000217	0.00332	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000217	0.00331	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000215	0.00329	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000212	0.00324	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000205	0.00314	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000201	0.00308	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.0002	0.00306	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000197	0.00301	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000186	0.00285	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000184	0.00281	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000176	0.00269	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000167	0.00256	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000164	0.00252	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000163	0.00249	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000151	0.00232	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000151	0.00232	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000146	0.00223	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000144	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000141	0.00215	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00014	0.00214	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000133	0.00204	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000132	0.00203	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000132	0.00202	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000127	0.00195	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000125	0.00192	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000116	0.00178	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000111	0.00169	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000109	0.00166	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.31e-05	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEP—polycystic ovary syndrome	9.11e-05	0.00139	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.12e-05	0.00124	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—POMC—polycystic ovary syndrome	7.82e-05	0.0012	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INS—polycystic ovary syndrome	7.78e-05	0.00119	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.53e-05	0.00115	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.52e-05	0.00115	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.15e-05	0.00109	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.75e-05	0.00088	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.92e-05	0.000752	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—polycystic ovary syndrome	3.4e-05	0.00052	CbGpPWpGaD
